The drug isn't a cure for cancer, the claim is it's "life extending," which parents will read as "hospice." There are already plenty of known treatments for cancer, and they already do what this one claims.
It's obvious that most funds are not buying in here, it's a biopharma news P&D. If funds were scooping this up, it would have climbed all day, no go, no takers. This died at 11:30am, pretty early.
Wishing it isn't so doesn't make it so. There are no orders, no contracts mentioned, it's descending gently downward towards the origin, as all of the inventory dumps of the last few months have done.
Happy trading!
News 
Market Data 
Discover 
AI
